Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning

Behavioural Brain Research

Volumn 253, Issue , 2013, Pages 9-16

  Klakotskaia, D ^a   Ramsey, A K ^a   Fowler, S W ^c   Serfozo, P ^b   Simonyi, A ^b   Schachtman, T R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AMN082; Conditioned taste aversion; LY379268; Metabotropic glutamate receptor; MMPIP; VU0155041

Indexed keywords

2 (3,5 DICHLOROPHENYLCARBAMOYL)CYCLOHEXANECARBOXYLIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 6 (4 METHOXYPHENYL) 5 METHYL 3 (4 PYRIDINYL)ISOXAZOLO[4,5 C]PYRIDIN 4(5H) ONE; LIGAND; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 2 LIGAND; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 3 LIGAND; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 7; N,N' DIBENZHYDRYLETHANE 1,2 DIAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LEARNING; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TASTE AVERSION;

AMN082; CONDITIONED TASTE AVERSION; LY379268; METABOTROPIC GLUTAMATE RECEPTOR; MMPIP; VU0155041;

AMINO ACIDS; ANILIDES; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZHYDRYL COMPOUNDS; BICYCLO COMPOUNDS, HETEROCYCLIC; CUES; CYCLOHEXANECARBOXYLIC ACIDS; EXCITATORY AMINO ACID AGENTS; LIGANDS; MALE; PYRIDONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SACCHARIN; SWEETENING AGENTS; TASTE;

EID: 84880625989     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.06.032     Document Type: Article

References (80)

1. Gravius A., Pietraszek M., Dekundy A., Danysz W. Metabotropic glutamate receptors as therapeutic targets for cognitive disorders. Current Topics in Medicinal Chemistry 2010, 10:187-206.
2. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behavioural Brain Research 2003, 140:1-47.
3. Simonyi A., Schachtman T.R., Christoffersen G.R.J. The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News and Perspectives 2005, 18:353-361.
4. Simonyi A., Schachtman T.R., Christoffersen G.R.T. Metabotropic glutamate receptor subtype 5 antagonism in learning and memory. European Journal of Pharmacology 2010, 639:17-25.
5. Neki A., Ohishi H., Kaneko T., Shigemoto R., Nakanishi S., Mizuno N. Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neuroscience Letters 1996, 202:197-200.
6. Petralia R.S., Wang Y.X., Niedzielski A.S., Wenthold R.J. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 1996, 71:949-976.
7. Lyon L., Kew J.N., Corti C., Harrison P.J., Burnet P.W. Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice. Synapse 2008, 62:842-850.
8. Linden A.M., Shannon H., Baez M., Yu J.L., Koester A., Schoepp D.D. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Psychopharmacology (Berl) 2005, 179:284-291.
9. Riaza Bermudo-Soriano C., Perez-Rodriguez M.M., Vaquero-Lorenzo C., Baca-Garcia E. New perspectives in glutamate and anxiety. Pharmacology Biochemistry and Behavior 2012, 100:752-774.
10. Yokoi M., Kobayashi K., Manabe T., Takahashi T., Sakaguchi I., Katsuura G., et al. Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science 1996, 273:645-647.
11. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44:5-21.
12. Cippitelli A., Damadzic R., Frankola K., Goldstein A., Thorsell A., Singley E., et al. Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: prevention by group II metabotropic glutamate receptor activation. Biological Psychiatry 2010, 67:823-830.
13. Corti C., Battaglia G., Molinaro G., Riozzi B., Pittaluga A., Corsi M., et al. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. Journal of Neuroscience 2007, 27:8297-8308.
14. Tamaru Y., Nomura S., Mizuno N., Shigemoto R. Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience 2001, 106:481-503.
15. Higgins G.A., Ballard T.M., Kew J.N., Richards J.G., Kemp J.A., Adam G., et al. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 2004, 46:907-917.
16. Valerio A., Ferraboli S., Paterlini M., Spano P.F., Barlati S. Identification of novel alternatively-spliced mRNA isoforms of metabotropic glutamate receptor 6 gene in rat and human retina. Gene 2001, 262:99-106.
17. Duty S. Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease. British Journal of Pharmacology 2010, 161:271-287.
18. Lindsley C.W., Hopkins C.R. Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature. Expert Opinion on Therapeutic Patents 2012, 22:461-481.
19. Battaglia G., Busceti C.L., Molinaro G., Biagioni F., Traficante A., Nicoletti F., et al. Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Neuroscience 2006, 26:7222-7229.
20. Betts M.J., O'Neill M.J., Duty S. Allosteric modulation of the group III mGlu(4) receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease. British Journal of Pharmacology 2012, 166:2317-2330.
21. Goudet C., Vilar B., Courtiol T., Deltheil T., Bessiron T., Brabet I., et al. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. FASEB Journal 2012, 26:1682-1693.
22. Amalric M., Lopez S., Goudet C., Fisone G., Battaglia G., Nicoletti F., et al. Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease. Neuropharmacology 2013, 66:53-64.
23. Gerlai R., Roder J.C., Hampson D.R. Altered spatial learning and memory in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. Behavioral Neuroscience 1998, 112:525-532.
24. Pekhletski R., Gerlai R., Overstreet L.S., Huang X.P., Agopyan N., Slater N.T., et al. Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. Journal of Neuroscience 1996, 16:6364-6373.
25. Chojnacka-Wójcik E., Tatarczyńska E., Pilc A. The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats. European Journal of Pharmacology 1997, 319:153-156.
26. Stachowicz K., Chojnacka-Wójcik E., Kłak K., Pilc A. Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling. Pharmacological Reports 2006, 58:820-826.
27. Stachowicz K., Chojnacka-Wójcik E., Kłak K., Pilc A. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Neuropharmacology 2007, 52:306-312.
28. Tatarczyńska E., Kłodzińska A., Kroczka B., Chojnacka-Wójcik E., Pilc A. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology (Berl) 2001, 158:94-99.
29. Wierońska J.M., Szewczyk B., Pałucha A., Brański P., Zieba B., Smiałowska M. Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala. Pharmacological Reports 2005, 57:734-743.
30. Kinoshita A., Shigemoto R., Ohishi H., van der Putten H., Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. Journal of Comparative Neurology 1998, 393:332-352.
31. Nicoletti F., Bockaert J., Collingridge G.L., Conn P.J., Ferraguti F., Schoepp D.D., et al. Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 2011, 60:1017-1041.
32. Boudin H., Doan A., Xia J., Shigemoto R., Huganir R.L., Worley P., et al. Presynaptic clustering of mGluR7a requires the PICK1 PDZ domain binding site. Neuron 2000, 28:485-497.
33. Enz R., Croci C. Different binding motifs in metabotropic glutamate receptor 7b for filamin A, protein phosphatase 1C, protein interacting with protein kinase C (PICK) 1 and syntenin allow the formation of multimeric protein complexes. Biochemical Journal 2003, 372:183-191.
34. Callaerts-Vegh Z., Beckers T., Ball S.M., Baeyens F., Callerts P.F., Cryan J.F., et al. Concomitant deficits in working memory and fear extinction and functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice. Journal of Neuroscience 2006, 26:6573-6582.
35. Masugi M., Shigemoto R., Muguruma K., Watanabe Y., Sansig G., van der Putten H., et al. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. Journal of Neuroscience 1999, 19:955-963.
36. Fendt M., Schmid S., Thakker D.R., Jacobson L.H., Yamamoto R., Mitsukawa K., et al. mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Molecular Psychiatry 2008, 13:970-979.
37. Lavreysen H., Dautzenberg F.M. Therapeutic potential of group III metabotropic glutamate receptors. Current Medicinal Chemistry 2008, 15:671-684.
38. Nunez-Jamarillo L., Ramirez-Lugo L., Herrera-Morales W., Miranda M.I. Taste memory formation: latest advances and challenges. Behavioural Brain Research 2010, 207:232-248.
39. Conditioned taste aversions: behavioral and neural processes 2009, Oxford Univ. Press, New York, NY. S. Reilly, T.R. Schachtman (Eds.).
40. Gal-Ben-Ari S., Rosenblum K. Molecular mechanisms underlying memory consolidation of taste information in the cortex. Frontiers in Behavioral Neuroscience 2011, 5:87.
41. Schachtman T.R., Bills C., Ghinescu R., Murch K., Serfozo P., Simonyi A. MPEP a selective metabotropic glutamate receptor 5 antagonist, attenuates conditioned taste aversion in rats. Behavioural Brain Research 2003, 141:177-182.
42. Mitsukawa K., Yamamoto R., Ofner S., Nozulak J., Pescott O., Lukic S., et al. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:18712-18717.
43. Suzuki G., Tsukamoto N., Fushiki H., Kawagishi A., Nakamura M., Kurihara H., et al. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. Journal of Pharmacology and Experimental Therapeutics 2007, 323:147-156.
44. Hikichi H., Nishino M., Fukushima M., Satow A., Maehara S., Kawamoto H., et al. Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice. European Journal of Pharmacology 2010, 639:99-105.
45. Bahi A. The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 prevents reinstatement of extinguished ethanol-induced conditioned place preference in mice. Pharmacology Biochemistry and Behavior 2012, 101:193-200.
46. Hikichi H., Murai T., Okuda S., Maehara S., Satow A., Ise S., et al. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridine-4(5H)-one (MMPIP), on the central nervous system in rodents. European Journal of Pharmacology 2010, 639:106-114.
47. Li X., Li J., Gardner E.L., Xi Z.X. Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2/3 mechanism in rats. Journal of Neurochemistry 2010, 114:1368-1380.
48. Imre G. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. CNS Drug Reviews 2007, 13:444-464.
49. Reiner A., Lafferty D.C., Wang H.B., Del Mar N., Deng Y.P. The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice. Neurobiology of Disease 2012, 47:75-91.
50. Duvoisin R.M., Villasana L., Davis M.J., Winder D.G., Raber J. Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges. Behavioural Brain Research 2011, 221:50-54.
51. Niswender C.M., Johnson K.A., Weaver C.D., Jones C.K., Xiang Z., Luo Q., et al. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Molecular Pharmacology 2008, 74:1345-1358.
52. Rappold V.A., Porter J.H., Llewellyn G.C. Evaluation of the toxic effects of aflatoxin B1 with a taste aversion paradigm in rats. Neurobehavioral Toxicology and Teratology 1984, 6:51-58.
53. Greco B., Lopez S., van der Putten H., Flor P.J., Amalric M. Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics 2010, 332:1064-1071.
54. Palucha A., Klak K., Branski P., van der Putten H., Flor P.J., Pilc A. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Psychopharmacology (Berl) 2007, 194:555-562.
55. Salling M.C., Faccidomo S., Hodge C.W. Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082. Pharmacology Biochemistry and Behavior 2008, 91:14-20.
56. Dragion W.B., McCleary G.E., McCleary P. A comparison of two methods of measuring conditioned taste aversions. Behavior Research Methods and Instrumentation 1971, 3:309-310.
57. Grote F.W., Brown R.T. Conditioned taste aversions: two-stimulus tests are more sensitive than one-stimulus tests. Behavior Research Methods and Instrumentation 1971, 3:311-312.
58. Elkins R.L. Individual differences in bait shyness: effects of drug dose and measurement technique. Psychological Record 1973, 23:349-358.
59. Reilly S., Bornovalova M.A. Conditioned taste aversion and amygdala lesions in the rat: a critical review. Neuroscience and Biobehavioral Reviews 2005, 29:1067-1088.
60. Batsell W.R., Best M.R. One bottle too many? Method of testing determines the detection of overshadowing and retention of taste aversions. Animal Learning and Behavior 1993, 21:154-158.
61. Thiele T.E., Kiefer S.W., Bailey S.A. Taste reactivity and consumption measures in the assessment of overshadowing: modulation of aversive, but not ingestive, reactivity. Psychonomic Bulletin and Review 1996, 3:199-203.
62. O'Connor R.M., Finger B.C., Flor P.J., Cryan J.F. Metabotropic glutamate receptor 7: at the interface of cognition and emotion. European Journal of Pharmacology 2010, 639:123-131.
63. Bills C., Schachtman T.R., Serfozo P., Gasparini F., Spooren W.P.J.M., Simonyi A. Metabotropic glutamate receptor 5 and latent inhibition using conditioned taste aversion. Behavioural Brain Research 2005, 157:71-78.
64. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. Journal of Neurochemistry 2000, 75:889-907.
65. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. Journal of Pharmacology and Experimental Therapeutics 2001, 299:12-20.
66. Pałucha-Poniewiera A., Brański P., Lenda T., Pilc A. The antidepressant-like action of mGlu7 receptor agonist, N,N'-Bis (Diphenylmethyl)-1,2-Ethanediamine (AMN082), is serotonin-dependent. Journal of Pharmacology and Experimental Therapeutics 2010, 334:1066-1074.
67. Sukoff Rizzo S.J., Leonard S.K., Gilbert A., Dollings P., Smith D.L., Zhang M.Y., et al. The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?. Journal of Pharmacology and Experimental Therapeutics 2011, 338:345-352.
68. Myers K.M., Davis M. Behavioral and neural analysis of extinction. Neuron 2002, 36:567-584.
69. Neugebauer V., Keele N.B., Shinnick-Gallagher P. Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro. Journal of Neuroscience 1997, 17:983-995.
70. Xi Z.X., Baker D.A., Shen H., Carson D.S., Kalivas P.W. Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. Journal of Pharmacology and Experimental Therapeutics 2002, 300:162-171.
71. Marek G.J., Aghajanian G.K. The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis. Biological Psychiatry 1998, 44:1118-1127.
72. Ugolini A., Large C.H., Corsi M. AMN082, an allosteric mGluR7 agonist that inhibits afferent glutamatergic transmission in rat basolateral amygdala. Neuropharmacology 2008, 55:532-536.
73. Li X., Gardner E.L., Xi Z.X. The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats. Neuropharmacology 2008, 54:542-551.
74. Ferreira G., Miranda M.I., De la Cruz V., Rodríguez-Ortiz C.J., Bermúdez-Rattoni F. Basolateral amygdala glutamatergic activation enhances taste aversion through NMDA receptor activation in the insular cortex. European Journal of Neuroscience 2005, 22:2596-2604.
75. Miranda M.I., Ferreira G., Ramirez-Lugo L., Bermudez-Rattoni F. Glutamatergic activity in the amygdala signals visceral input during taste memory formation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11417-11422.
76. Bielavska E., Miksik I., Krivanek J. Glutamate in the parabrachial nucleus of rats during conditioned taste aversion. Brain Research 2000, 887:413-417.
77. Guzmán-Ramos K., Osorio-Gómez D., Moreno-Castilla P., Bermúdez-Rattoni F. Off-line concomitant release of dopamine and glutamate involvement in taste memory consolidation. Journal of Neurochemistry 2010, 114:226-236.
78. Parsons C.G., Stöffler A., Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology 2007, 53:699-723.
79. Hampson R.E., Deadwyler S.A. Cannabinoids, hippocampal function and memory. Life Sciences 1999, 65:715-723.
80. Swanson C.J., Bures M., Johnson M.P., Linden A.M., Monn J.A., Schoepp D.D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nature Reviews Drug Discovery 2005, 4:131-144.